JHVEPhoto/iStock Editorial via Getty Images
Shares of Becton, Dickinson (NYSE:BDX) traded sharply lower on Thursday after the medical equipment maker lowered its full-year earnings and growth outlook with its Q2 fiscal 2025 financials, leading to downgrades at Bank of America and Wells Fargo.
While BD’s (BD) non-GAAP